🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ji Son

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-5130-4763

Also affiliated with Seoul National University Children's Hospital

MedicineBiochemistry, Genetics and Molecular BiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?”.

Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.028
N/A
0DataRank · unranked
19 citations

Ting‐Tai Yen, Rebecca L. Stone, Stephanie L. Wethington, Caitlin Carr, Ji Son +24 more

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer

Journal of Immunotherapy and Precision Oncology(2023)10.36401/jipo-22-23
N/A
0DataRank · unranked
1 citations

Heather Lin, Siqing Fu, Amadeo B. Biter, Ecaterina E. Dumbrava, Daniel D. Karp +15 more

Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2819
N/A
0DataRank · unranked
12 citations

Yingao Zhang, Heather Lin, Oriol Mirallas, Pablo Álvarez Ballesteros, Mirella Nardo +19 more

Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.583
N/A
0DataRank · unranked
5 citations

Anne M. Mills, Brooke E. Howitt, Rachel N. Grisham, Elizabeth D. Euscher, Hyun Soo Kim +16 more